https://www.selleckchem.com/pr....oducts/anlotinib-al3
Due to the abusing of antibiotics, multiple drug-resistant pathogenic bacteria have increasingly emerged. It increases the difficulty of treatment as it directly affects public health by diminishing potency of existing antibiotics. Developing alternative therapeutic strategies is the urgent need to reduce the mortality and morbidity related to drug-resistant bacterial infections. In the past 10 to 20 years, nanomedicines have been widely studied and applied as an antibacterial agent. It has become a novel tool for fighting resi
Mi piace
Commento
Condividi
